22,758 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Amgen Acquisitions

Amgen has acquired 26 companies and its latest acquisition was Dark Blue Therapeutics on Jan 2026

Unlock 23 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Dark Blue Therapeutics

Jan 2026

Source »
$840M
-
Horizon Therapeutics plc

Dec 2022

Source »
$27.8B
Horizon Therapeutics is an Ireland-based biotechnology company that develops and commercializes novel therapeutics for the treatment of autoimmune and inflammatory diseases.
ChemoCentryx, Inc.

Aug 2022

Source »
$3.7B
ChemoCentryx is a California-based biopharmaceutical company that develops orally-administered therapeutics for the treatment of cancer, inflammatory and autoimmune diseases.
Teneobio, Inc.

Jul 2021

Source »
$900M
Teneobio is a California-based clinical-stage biotechnology company that researches and develops biotherapeutic antibodies to treat cancer and infectious diseases.
Rodeo Therapeutics Corporation

Mar 2021

Source »
$55M
Rodeo is a Washington-based pharmaceutical company that researches and develops small-molecular therapeutics for the treatment of inflammatory bowel diseases.

Frequently Asked Questions about Amgen

  1. What companies did Amgen acquire?

    Companies acquired by Amgen include Dark Blue Therapeutics, Horizon Therapeutics and ChemoCentryx

  2. How many acquisitions does Amgen have?

    Amgen has acquired 26 companies including Dark Blue Therapeutics, Horizon Therapeutics and ChemoCentryx.

  1. How many acquisitions did Amgen make in 2026?

    In 2026 Amgen acquired 1 companies including Dark Blue Therapeutics.